Four national cancer research organizations, spearheaded by Seattle’s Fred Hutch Cancer Center, will work together in an unprecedented alliance to… Read More
Arzeda, a protein design startup that generates new enzymes for industrial, agricultural and other applications, announced a $38 million investment… Read More
Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone… Read More
Talus Bioscience on Tuesday announced $11.2 million in venture capital funding to advance its drug discovery program for hard-to-treat diseases. … Read More
Alpenglow Biosciences, a Seattle biotech startup that develops 3D spatial biology imaging technology, announced Thursday that it landed a $2… Read More
Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors,… Read More
If Elon Musk’s Neuralink brain-implant venture succeeds in its effort to create next-generation brain implants for artificial vision, the devices… Read More
The Allen Institute’s OpenScope program lets scientists study the weird workings of the brain — for instance, how magic mushrooms work their… Read More
Viome, the Bellevue, Wash.-based wellness and diagnostics company, is putting its efforts around preventive healthcare and longevity where its mouth… Read More
Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed… Read More
Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million… Read More
Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for… Read More
The Allen Institute for Immunology, a division of the Seattle-based Allen Institute, is teaming with Seattle Children’s Research Institute to… Read More
Seattle startup Dopl Technologies has developed a telerobotic ultrasound system intended to bring specialist care to patients in rural areas.… Read More
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion… Read More
ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator,… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
